Executive Committee


Tamar Thompson

Head, Corporate Affairs | Alexion/AstraZeneca Rare Disease

Vice Chair

Jeff Elton

Chief Executive Officer | ConcertAI


Jason Cole

Chief Executive Officer I SalioGen Therapeutics

Past Chair

Pam Randhawa

Founder & Chief Executive Officer | Empiriko



Carolina Alarco

Founder & Principal of Bio Strategy Advisors | Co-Founder & C-Chair of Latinos in Bio

Chip Clark

Entrepreneur-in-Residence | SR One Capital Management

John Dunlop

Chief Scientific Officer | Aliada Therapeutics

Eileen A. Elliott

Eileen Elliott

Executive Director of Scientific Affairs & External Partnership & Kendall Square Site Lead | Pfizer

Brian Foard

Brian Foard

Executive Vice President, Head of Specialty Care | Sanofi

Luba Greenwood

Managing Partner, Dana-Farber Cancer Institute, Binney Street Capital (BSC) | Professor, Harvard University

Sue Hager

Chief Marketing Officer | Andreessen Horowitz Bio+Health

Dennis Huang

Chief Technical Operations Officer & EVP Gene Therapy Operations | Ultragenyx

Emma Lees

Emma Lees

Senior Vice President, Head of Mechanisms of Cancer Resistance Thematic Research Center | Bristol Myers Squibb

Lizabeth Leveille

Vice President & Head, BD&L Boston & European Innovation Hubs & Discovery Transactions | Merck & Co

Liz Lewis

Head of Global Oncology Patient Value, Policy & Access | Takeda

Evan Lippman

Evan Lippman

Chief Corporate Development & Strategy Officer | Alnylam

David Meeker

Chair, President, & Chief Executive Officer | Rhythm Pharmaceuticals

Mike Shafer

SVP and President Pharma Services Group, Thermo Fisher Scientific